Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Change in Inventory: 2023-2025

Historic Change in Inventory for Phathom Pharmaceuticals (PHAT) over the last 2 years, with Sep 2025 value amounting to -$395,000.

  • Phathom Pharmaceuticals' Change in Inventory fell 194.50% to -$395,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 95.60%. This contributed to the annual value of $6.1 million for FY2024, which is 34.95% down from last year.
  • Phathom Pharmaceuticals' Change in Inventory amounted to -$395,000 in Q3 2025, which was down 121.35% from $1.9 million recorded in Q2 2025.
  • Phathom Pharmaceuticals' 5-year Change in Inventory high stood at $12.3 million for Q1 2025, and its period low was -$395,000 during Q3 2025.
  • In the last 3 years, Phathom Pharmaceuticals' Change in Inventory had a median value of $418,000 in 2024 and averaged $3.3 million.
  • Within the past 5 years, the most significant YoY rise in Phathom Pharmaceuticals' Change in Inventory was 2,863.46% (2025), while the steepest drop was 194.50% (2025).
  • Phathom Pharmaceuticals' Change in Inventory (Quarterly) stood at $9.3 million in 2023, then slumped by 40.24% to $5.6 million in 2024, then plummeted by 194.50% to -$395,000 in 2025.
  • Its Change in Inventory stands at -$395,000 for Q3 2025, versus $1.9 million for Q2 2025 and $12.3 million for Q1 2025.